These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1364264)

  • 21. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?
    Underwood M; Bartlett J; Reeves J; Gardiner DS; Scott R; Cooke T
    Cancer Res; 1995 Jun; 55(11):2422-30. PubMed ID: 7757996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
    Lee EY; Cibull ML; Strodel WE; Haley JV
    Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder.
    Arima J; Imazono Y; Takebayashi Y; Nishiyama K; Shirahama T; Akiba S; Furukawa T; Akiyama S; Ohi Y
    Cancer; 2000 Mar; 88(5):1131-8. PubMed ID: 10699904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.
    Press MF; Hung G; Godolphin W; Slamon DJ
    Cancer Res; 1994 May; 54(10):2771-7. PubMed ID: 7909495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of beta-human chorionic gonadotropin (beta-hCG) in non-trophoblastic elements of transitional cell carcinoma of the bladder: possible relationship with the prognosis.
    Bacchi CE; Coelho KI; Goldberg J
    Rev Paul Med; 1993; 111(3):412-6. PubMed ID: 8108635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues.
    Gullick WJ; Hughes CM; Mellon K; Neal DE; Lemoine NR
    J Pathol; 1991 Aug; 164(4):285-9. PubMed ID: 1681040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique.
    Orlando C; Sestini R; Vona G; Pinzani P; Bianchi S; Giacca M; Pazzagli M; Selli C
    J Urol; 1996 Dec; 156(6):2089-93. PubMed ID: 8911396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
    Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
    Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The molecular biology of bladder carcinoma].
    Moreno Sierra J; Maestro de las Casas ML; Chicharro Almarza J; Ortega Heredia MD; López García-Asenjo J; Merino Sánchez C; Blanco Jiménez E; Silmi Moyano A; Rsesel Estévez L
    Arch Esp Urol; 1997 Oct; 50(8):855-66. PubMed ID: 9463283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer.
    Lipponen P
    Eur J Cancer; 1993; 29A(5):749-53. PubMed ID: 8097100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma.
    Sato K; Moriyama M; Mori S; Saito M; Watanuki T; Terada K; Okuhara E; Akiyama T; Toyoshima K; Yamamoto T
    Cancer; 1992 Nov; 70(10):2493-8. PubMed ID: 1358427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.
    Nguyen PL; Swanson PE; Jaszcz W; Aeppli DM; Zhang G; Singleton TP; Ward S; Dykoski D; Harvey J; Niehans GA
    Am J Clin Pathol; 1994 Feb; 101(2):166-76. PubMed ID: 7906919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
    Berner A; Jacobsen AB; Fosså SD; Nesland JM
    Histopathology; 1993 Apr; 22(4):327-33. PubMed ID: 8099896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.